Please login to the form below

Not currently logged in
Email:
Password:

companion diagnostic

This page shows the latest companion diagnostic news and features for those working in and with pharma, biotech and healthcare.

EMA starts firming up its stance on personalised medicines

EMA starts firming up its stance on personalised medicines

New draft European guidelines on personalised medicines and companion diagnostics are expected to be released by December 2018. ... As diagnostic medical devices, companion diagnostics do not fall within the oversight of the EMA, but the regulator is set

Latest news

More from news
Approximately 1 fully matching, plus 65 partially matching documents found.

Latest Intelligence

  • Harnessing complexity Harnessing complexity

    This delicate balance between companion diagnostics' clinical utility and their potential confounding impact on patient treatment is a growing dilemma. ... Answering this question in full requires a scientific journey to better understand what a

  • Diagnostics are rising up the pharma value chain Diagnostics are rising up the pharma value chain

    Diagnostic drivers. It's not just this idea of changing public attitudes that is creating renewed interest in the diagnostics sector; the sector is also influenced by the wider forces affecting ... GlaxoSmithKline and Boehringer Ingelheim have had

  • Deal Watch table for June 2014 Deal Watch table for June 2014

    50. NanoString Technologies/ Celgene. Development. Development of a companion diagnostic assay.

  • Pharma deals during June 2014 Pharma deals during June 2014

    a deal with NanoString Technologies for the development of a companion diagnostic assay to support the development of Revlimid for treatment of Diffuse Large B-Cell Lymphoma at a more modest

  • Interview: John Dineen, GE Healthcare Interview: John Dineen, GE Healthcare

    some of these markers can be converted into a companion diagnostic product after the completion of a late-stage clinical trial. ... We can then ensure our diagnostic is closely coupled with the therapeutic capability.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics